PR
Peter Rahmer (See remarks) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Relay Therapeutics, Inc. (RLAY). The largest single filing was $954K of RLAY (50,000 sh × $19.09, as filed), executed Jun 30. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$954K
shares × price, as filed
Last traded
Jun 30
Filed Jul 2
Median ADV $74.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
RLAYRecent filings
RLAYSALE
Relay Therapeutics, Inc.
View filing →
$954K50,000 sh × $19.09
Exec Jun 30
Filed Jul 2 · 4:12 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $300K
40,529 sh across 2 lots
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $121K
26,541 sh × $4.55
Exec Jan 29 2025
Filed Jan 30 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $272K
64,333 sh across 2 lots
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET